Dermata Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. 

CEO
Gerald T. Proehl
CEOGerald T. Proehl
Employees
8
Employees8
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
8
Employees8

DRMA Key Statistics

Market cap
4.41M
Market cap4.41M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
Dividend yield
Average volume
86.17K
Average volume86.17K
High today
$0.6974
High today$0.6974
Low today
$0.6499
Low today$0.6499
Open price
$0.6688
Open price$0.6688
Volume
42.07K
Volume42.07K
52 Week high
$5.00
52 Week high$5.00
52 Week low
$0.5739
52 Week low$0.5739

People also own

Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.